For an example, using gemcitabine and cisplatin, the standard chemotherapy regimen for advanced bladder urothelial carcinomas, on xenograft tumors in mice demonstrated that chemotherapy-resistant bladder cancer stem cells express K14 (Figure 2A) [88]. This evidence concerns the gene KRT14 and urinary bladder carcinoma.